» Articles » PMID: 24604240

Intraperitoneal Administration of Fetuin-A Attenuates D-galactosamine/lipopolysaccharide-induced Liver Failure in Mouse

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2014 Mar 8
PMID 24604240
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Fulminant hepatic failure (FHF) is a devastating syndrome, which sometimes results in death or liver transplantation, in which inflammation would aggravate the development of fetuin-A which would act as an anti-inflammatory factor and may be an available approach to attenuate FHF.

Aims: The purpose of this study was to investigate the effects of fetuin-A on D-galactosamine/lipopolysaccharide (D-GalN/LPS)-induced liver failure in mice.

Methods: A mouse model of FHF induced by D-GalN/LPS was established and fetuin-A was injected intraperitoneally prior to D-GalN/LPS treatment. At different time points after D-GalN/LPS intervention, serum TNF-α and IL-6 levels were measured by ELISA. Fetuin-A mRNA and protein expression in liver tissues was assessed by RT-PCR, Western blotting and immunohistochemical staining. Besides, an observation of liver tissue injury, the apoptosis of hepatocytes, was analyzed by TUNEL assay.

Results: Expression of fetuin-A mRNA and protein in liver tissue were significantly and gradually decreased after D-GalN/LPS administration. A pre-intervention of exogenous fetuin-A significantly improved the liver function, decreased TNF-α and IL-6 expression in peripheral blood, and liver tissue inhibited hepatocyte apoptosis responded to D-GalN/LPS induction so as to decrease the mortality rates of FHF mouse. Meanwhile, fetuin-A was negatively correlated with the hepatic pathological score and TNF-α protein staining in FHF mouse.

Conclusions: An intraperitoneal injection of fetuin-A attenuates D-GalN/LPS-induced FHF in mice. Fetuin-A might be a protective agent of liver damage partly through inhibiting liver inflammatory response and hepatocyte apoptosis.

Citing Articles

Histopathological effects of hypervitaminosis-D and the protective role of fetuin-A in renal, hepatic, and cardiac tissues in a murine model.

Mohamed M, Hussein M, Moustafa S, Rahmani Y, Ahmed Durrani T, Ali S Sci Rep. 2025; 15(1):1078.

PMID: 39775139 PMC: 11706989. DOI: 10.1038/s41598-025-85200-1.


Effect of fetuin-A on adenine-induced chronic kidney disease model in male rats.

Ashour W, Zamzam M, Sayed Ali H, Ebrahim R Iran J Basic Med Sci. 2023; 26(5):511-516.

PMID: 37051102 PMC: 10083833. DOI: 10.22038/IJBMS.2023.66346.14584.


Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients - a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown.

Iacob S, Iacob D Front Endocrinol (Lausanne). 2022; 13:814209.

PMID: 35355551 PMC: 8959898. DOI: 10.3389/fendo.2022.814209.


Fetuin-A exerts a protective effect against experimentally induced intestinal ischemia/reperfusion by suppressing autophagic cell death.

El-Malkey N, Alsemeh A, Ashour W, Hassan N, Edrees H Exp Biol Med (Maywood). 2021; 246(11):1307-1317.

PMID: 33653159 PMC: 8371312. DOI: 10.1177/1535370221995207.


FGF23 and Fetuin-A Interaction in the Liver and in the Circulation.

Mattinzoli D, Ikehata M, Tsugawa K, Alfieri C, Dongiovanni P, Trombetta E Int J Biol Sci. 2018; 14(6):586-598.

PMID: 29904273 PMC: 6001652. DOI: 10.7150/ijbs.23256.


References
1.
Nauta A, Daha M, van Kooten C, Roos A . Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol. 2003; 24(3):148-54. DOI: 10.1016/s1471-4906(03)00030-9. View

2.
Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R . The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000; 32(4 Pt 1):734-9. DOI: 10.1053/jhep.2000.17687. View

3.
Szweras M, Liu D, Partridge E, Pawling J, Sukhu B, Clokie C . alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem. 2002; 277(22):19991-7. DOI: 10.1074/jbc.M112234200. View

4.
Denecke B, Graber S, Schafer C, Heiss A, Woltje M, Jahnen-Dechent W . Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J. 2003; 376(Pt 1):135-45. PMC: 1223762. DOI: 10.1042/BJ20030676. View

5.
Lian L, Jin X, Wu Y, Cai X, Lee J, Nan J . Hepatoprotective effects of Sedum sarmentosum on D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure. J Pharmacol Sci. 2010; 114(2):147-57. DOI: 10.1254/jphs.10045fp. View